Showing results (51-60 of 106) with videos related to
Sort By:
Pageof 11
Drug and Alcohol Dependence|June 26, 2017
Body mass index, body dissatisfaction and adolescent smoking initiationLaurence J Howe, Lea Trela-Larsen, Michelle Taylor, et al.Bioorganic & Medicinal Chemistry|November 18, 2005
Synthesis and characterization of selective dopamine D2 receptor antagonistsSuwanna Vangveravong, Elizabeth McElveen, Michelle Taylor, et al.Journal of Medicinal Chemistry|September 9, 2008
Structure-activity relationships for a novel series of dopamine D2-like receptor ligands based on N-substituted 3-aryl-8-azabicyclo[3.2.1]octan-3-olNoel M Paul, Michelle Taylor, Rakesh Kumar, et al.Molecules (Basel, Switzerland)|June 2, 2021
Evaluation of Substituted N-Phenylpiperazine Analogs as D3 vs. D2 Dopamine Receptor Subtype Selective LigandsBoeun Lee, Michelle Taylor, Suzy A Griffin, et al.Immunobiology|May 3, 2011
Influence of 1,25-dihydroxy vitamin D3 on TLR4-induced activation of antigen presenting cells is dependent on the order of receptor engagementVandana Gambhir, Julia Kim, Sarah Siddiqui, et al.International Journal of Molecular Sciences|January 8, 2023
Design and Synthesis of Conformationally Flexible Scaffold as Bitopic Ligands for Potent D3-Selective AntagonistsHo Young Kim, Ji Youn Lee, Chia-Ju Hsieh, et al.Molecules (Basel, Switzerland)|January 11, 2024
Design and Synthesis of D3R Bitopic Ligands with Flexible Secondary Binding Fragments: Radioligand Binding and Computational Chemistry StudiesGui-Long Tian, Chia-Ju Hsieh, Michelle Taylor, et al.Journal of Medicinal Chemistry|February 26, 2011
Synthesis and pharmacological evaluation of fluorine-containing D₃ dopamine receptor ligandsZhude Tu, Shihong Li, Jinquan Cui, et al.ACS Chemical Neuroscience|July 17, 2018
Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype SelectivityHamed S Hayatshahi, Kuiying Xu, Suzy A Griffin, et al.Pharmacology|August 15, 2013
The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibitionRenqi Huang, Suzy A Griffin, Michelle Taylor, et al.Pageof 11